Posts

WCLC 2023 | Dr. Harpole: Surgical outcomes from AEGEAN trial and subgroup analyses of patients who were EGFR-mutant

WCLC 2023 | Dr. Drilon: Advances in MET Target therapy released in 2023 WCLC

WCLC 2023 | Acceptance Speech by 2023 Distinguished Service Award Winner Dr. Ramalingam

WCLC 2023 |Dr. Reguart reviews three important small cell lung cancer immunotherapy studies

WCLC 2023 | Talking with the co-chairs Dr. Hegi-Johnson about the theme and important issues

WCLC 2023 |Dr. Gainor reviews IMpower151: Is the high percentage of patients with EGFR mutations, the reason for the research’s failure ?

WCLC 2023 | Talking with Dr. Bestvina about MA16 - Innovations in the Treatment of Stage III NSCLC

WCLC 2023 | Dr. Liu：Chemo-immunotherapy offers long-term survival benefit for ES-SCLC patients

WCLC 2023 | Dr. Johnson：Antibody Drug Conjugate (ADC) targeting B7-H3 shows efficient and durable efficacy in patients with refractory SCLC